Take Solutions is currently trading at Rs. 104.10, up by 0.75 points or 0.73% from its previous closing of Rs. 103.35 on the BSE.
The scrip opened at Rs. 103.90 and has touched a high and low of Rs. 106.20 and Rs. 103.50 respectively. So far 23332 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 186.90 on 03-Mar-2015 and a 52 week low of Rs. 31.50 on 14-Aug-2014.
Last one week high and low of the scrip stood at Rs. 109.20 and Rs. 96.00 respectively. The current market cap of the company is Rs. 1271.74 crore.
The promoters holding in the company stood at 68.36% while Institutions and Non-Institutions held 1.32% and 30.32% respectively.
TAKE Solutions, a global business technology solutions provider, has been awarded a patent by the United States Patent and Trademark Office (USPTO) for its ‘Method for Optimizing Clinical Data Standardization’. This process leverages the company’s Clinical Accelerators to reduce the time taken to standardize trial data by over 50% (when compared to standardization without the accelerators), thus reducing time to market.
At the heart of the patented Clinical Data Standardization Process are the company’s Clinical Accelerators, a set of macros that accelerate the Clinical Data Standardization process where raw data from clinical trials is standardized and transformed into CDISC SDTM format. The process includes various pre-defined steps that convert raw data into tabular datasets. This enables regulators to easily understand the data, as well as enables easy analysis of trial data.
This process is delivered by Navitas, the Life Sciences arm of TAKE Solutions. The Clinical Data Services team offers its clients the benefit of company's deep domain expertise in Clinical Data solutions including - Clinical Data Standardisation, Clinical Data Management, Statistical Programming, and Data Standards.
Take Solutions is a supply chain partner of choice for large manufacturers and distributors in the high-tech, pharma/medical, industrial products/services, and consumer packaged goods industries who need to help maximize their investment in Oracle, but minimize the cost and risk of customizations.
| Company Name | CMP |
|---|---|
| TCS | 4224.45 |
| Infosys | 1942.60 |
| HCL Tech. | 1799.30 |
| Wipro | 287.95 |
| Tech Mahindra | 1680.00 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Don't miss out! First 10 users today get it FREE
With this 4 hrs Masterclass, you’ll be able to:
Download APP
